China Shineway Pharmaceutical Group Ltd (2877) - Financial and Strategic SWOT Analysis Review



China Shineway Pharmaceutical Group Ltd (China Shineway) is a pharmaceutical company that offers development, manufacture and sales of Chinese medicines. The company’s products comprise shenmai injection, qingkailing injection, huangqi injection, shuxiening injection, wufu xinnaoqing soft capsules, qingkailing soft capsules, coryza soft capsules, and vitamin E soft capsules, among others. It provides banlangen granules, ganmao qingre granules, yening granules, cefalexin granules, xiesaitong dripping pills, liuwei dihuang wan, and aspirin tablets. China Shineway offers products in the forms of injection, soft capsule and granules. The company’s products are used in treatment of coronary heart disease, viral cardiac muscle inflammation, chronic pulmonary heart disease, cardiac cerebrovascular diseases and others. It operates manufacturing facilities in Hong Kong. China Shineway is headquartered in Wanchai, Hong Kong.

China Shineway Pharmaceutical Group Ltd Key Recent Developments

Aug 30,2019: China Shineway Pharmaceutical Group: 2019 Interim results announcement
Jul 02,2019: China Shineway Pharmaceutical Group: Cessation of Executive Director and Chief Executive Officer
May 03,2019: China Shineway Pharmaceutical Group: Turnover for the first quarter of 2019

This comprehensive SWOT profile of China Shineway Pharmaceutical Group Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of China Shineway Pharmaceutical Group Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
 

"

Section 1 - About the Company

China Shineway Pharmaceutical Group Ltd - Key Information
China Shineway Pharmaceutical Group Ltd - Overview
China Shineway Pharmaceutical Group Ltd - Key Employees
China Shineway Pharmaceutical Group Ltd - Key Employee Biographies
China Shineway Pharmaceutical Group Ltd - Key Operational Heads
China Shineway Pharmaceutical Group Ltd - Major Products and Services
China Shineway Pharmaceutical Group Ltd - History
China Shineway Pharmaceutical Group Ltd - Company Statement
China Shineway Pharmaceutical Group Ltd - Locations And Subsidiaries
China Shineway Pharmaceutical Group Ltd
Head Office
Other Locations & Subsidiaries

Section 2 - Company Analysis

China Shineway Pharmaceutical Group Ltd - Business Description
China Shineway Pharmaceutical Group Ltd - Corporate Strategy
China Shineway Pharmaceutical Group Ltd - SWOT Analysis
SWOT Analysis - Overview
China Shineway Pharmaceutical Group Ltd - Strengths
China Shineway Pharmaceutical Group Ltd - Weaknesses
China Shineway Pharmaceutical Group Ltd - Opportunities
China Shineway Pharmaceutical Group Ltd - Threats
China Shineway Pharmaceutical Group Ltd - Key Competitors

Section 3 - Company Financial Performance Charts

China Shineway Pharmaceutical Group Ltd - Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

Section 4 - Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer


Note*: Some sections may be missing if data is unavailable for the company
 


List Of Tables



China Shineway Pharmaceutical Group Ltd, Key Information
China Shineway Pharmaceutical Group Ltd, Key Ratios
China Shineway Pharmaceutical Group Ltd, Share Data
China Shineway Pharmaceutical Group Ltd, Major Products and Services
China Shineway Pharmaceutical Group Ltd, History
China Shineway Pharmaceutical Group Ltd, Key Employees
China Shineway Pharmaceutical Group Ltd, Key Employee Biographies
China Shineway Pharmaceutical Group Ltd, Key Operational Heads
China Shineway Pharmaceutical Group Ltd, Other Locations
China Shineway Pharmaceutical Group Ltd, Subsidiaries
China Shineway Pharmaceutical Group Ltd, Key Competitors
China Shineway Pharmaceutical Group Ltd, SWOT Analysis
China Shineway Pharmaceutical Group Ltd, Ratios based on current share price
China Shineway Pharmaceutical Group Ltd, Annual Ratios
China Shineway Pharmaceutical Group Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
 


List Of Figures



China Shineway Pharmaceutical Group Ltd, Performance Chart
China Shineway Pharmaceutical Group Ltd, Ratio Charts
 


Antibiotics for Multidrug-Resistant Gram-positive Bacteria Market in China 2023

Antibiotics for multidrug-resistant Gram-positive bacteria are a critical area of research and development as these types of bacteria have developed resistance to multiple types of antibiotics, making them difficult to

USD 675 View Report

Ulcerative Colitis (UC) Market in China 2023

Ulcerative colitis (UC) is a chronic inflammatory bowel disease that affects the lining of the large intestine (colon) and rectum. It is characterized by inflammation, ulcers, and bleeding in the

USD 675 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available